Shandong Cancer Hospital and Institute
Shandong Cancer Hospital runs one of China's largest radiotherapy departments under Jinming Yu, with a proton therapy centre and PET-guided adaptive radiotherapy; it has led Chinese trials combining radiotherapy with immunotherapy in lung and oesophageal cancer and studies of brain metastasis management.
Overview
Shandong Cancer Hospital and Institute, founded in 1958 and affiliated to Shandong First Medical University and the Shandong Academy of Medical Sciences, is best known for radiation oncology under Jinming Yu, with one of the largest radiotherapy departments in China, a proton therapy centre and heavy investment in PET-guided and adaptive radiotherapy. It has led Chinese trials combining radiotherapy with immunotherapy in lung and oesophageal cancer and studies of brain metastasis management. The hospital also runs strong thoracic surgery, breast and gynaecological programmes and a provincial cancer registry.
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-22.
Matched to Shandong Tumor Hospital, including child institutions. 1,034 works · 9,155 citations · 74% open access · 19% clinical trials · 2% reviews.
- Jinming Yu53 works
- Ligang Xing40 works
- Dawei Chen40 works
- Xiangjiao Meng38 works
- Yuping Sun33 works
- Zuoxing Niu30 works
- Hui Zhu28 works
- Linlin Wang26 works
- Jinming Yu24 works
- Jinbo Yue20 works
- Radiation oncology
- Proton therapy
- Radio-immunotherapy trials
- Thoracic oncology
Similar pages
not linked directly; found by shared links- OpportunityDLL3 imaging for small-cell lung cancer
Shares Small-cell lung cancer, PET/CT.
- TechnologyCT (computed tomography)
Shares Small-cell lung cancer, PET/CT.
- TechnologySomatostatin receptor PET (68Ga/64Cu-DOTATATE)
Shares Small-cell lung cancer, PET/CT.
- IndicationNon-small cell lung cancer
Shares Small-cell lung cancer, PET/CT.